Navigation Links
I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
Date:2/23/2010

LA JOLLA, Calif., Feb. 23 /PRNewswire/ -- I3 Corporation announced today that the Company will be presenting on its lead product, the Q-FLO™ closed system, as a superior alternative to conventional closed systems for medication transport and delivery, at the In3 West Conference on March 4-5, 2010, at the Venetian Resort in Las Vegas, NV.

The Q-FLO™ is I3's lead product that encompasses a male and female luer lock mechanism for closed system medication transport and delivery.  The Q-FLO™ offers unique features and benefits for medication delivery, which include: a) a closed, no drop, valved connection system preventing drips and spillage of cytotoxic drugs, b) convenient locking mechanism allowing for a fast and easy mechanism to establish a patent connection; c) Passive 'Fool Proof' Safety System which seals off upon disconnection to help prevent exposure to hazardous compounds; d) first ever Visual Indicator that provides for a clear, color coded, visual confirmation of the status of the connection; e) the lowest internal residual volume of any closed system on the market; f) rotational actuation, which allows for a pumping action within the male luer connector offering the flexibility of creating a negative, positive, or neutral bolus effect, and finally g) safe material composition, which is entirely Latex, DEHP, and Silicon-free, making the Q-FLO™ an ideal connector system for the entire spectrum of chemotherapy and nuclear medicine drugs.

"The Q-FLO™ represents a significant advance in the state of the art of closed system devices, offering improved safety and convenience for healthcare workers administering cytotoxic drugs to patients around the world," stated Babak Nemati, Ph.D., President & CEO of I3.  "We are proud of the accomplishments of our design and development team, and we look forward to the commercial launch of this important product line with our distribution partners later this year."

In the current hospital environment, thousands of pharmacists, nurses, physicians and other caregivers may encounter a serious threat to their own physical and reproductive health, on a daily basis, through inadvertent exposure to cytotoxic drugs, such as chemotherapy, antivirals, antibiotics, hormones, nuclear medicine drugs.  The US federal government estimates that 5.5 million healthcare workers continue to be exposed to these substances each year.  Advances in closed systems such as the I3 Q-FLO™ offer the promise of creating a safe working environment for healthcare providers worldwide.

About I3 Corporation (www.infusioninnovations.net)

I3 is a La Jolla, California, based emerging medical device company focused on the design and development of innovative products for improved safety of the hospital environment.  Founded in 2006, I3 has a strong proprietary portfolio of products ranging from needle-less injection site connectors, to safety syringes, and bio-diagnostic sampling devices.  The fundamental driving philosophy behind our products is bringing key engineering innovation to improve safety, ease of use, and functionality of established hospital based products.

For more information, please contact us at info@infusioninnovations.net.

SOURCE I3 Corporation

Back to top

RELATED LINKS
http://www.infusioninnovations.net

'/>"/>

SOURCE I3 Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
2. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
3. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
7. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
8. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
9. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
10. Innovative Brain Scanning for Alzheimers Screening Unveiled
11. Gates Foundation Seeks Proposals for Innovative Global Health Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):